Return
Company Page
Oxford Drug Design
Founders
Oxford Drug Design is a UK-based AI-driven drug discovery company, originally spun out of the University of Oxford Chemistry Department. The company integrates generative AI, machine learning, and proprietary tRNA synthetase expertise through its SynthAI platform to design and develop first-in-class therapeutics, with a primary focus on oncology and anti-infective treatments targeting unmet medical needs.
Company Founded in 2001
Healthtech & Biotech